Inventor · disambiguated record
Natarajan Muthusamy
Also filed as: MUTHUSAMY NATARAJAN
9 granted patents·12 pending applications·85 citations·filing 2006–2024
89Inventor score
Top patents by PatentIndex Score
21 records- 0195US10357514B2Treatment of cancer using anti-CD19 Chimeric Antigen ReceptorUNIV PENNSYLVANIA·Filed 2015·Granted Jul 23, 2019·18 cites·45 claims
- 0294US10695350B2Methods of treating and preventing graft versus host diseasePHARMACYCLICS LLC·Filed 2019·Granted Jun 30, 2020·6 cites·8 claims
- 0393US9795604B2Methods of treating and preventing graft versus host diseasePHARMACYCLICS LLC·Filed 2014·Granted Oct 24, 2017·19 cites·55 claims
- 0493US8309768B2FTY720-derived anticancer agentsCHEN CHING-SHIH·Filed 2011·Granted Nov 13, 2012·9 cites·16 claims
- 0591US10463668B2Methods of treating and preventing graft versus host diseasePHARMACYCLICS LLC·Filed 2017·Granted Nov 5, 2019·8 cites·4 claims
- 0691US9717731B2TEC family kinase inhibitor adjuvant therapyPHARMACYCLICS LLC·Filed 2013·Granted Aug 1, 2017·14 cites·6 claims
- 0788US2025345335A1Methods of treating and preventing graft versus host diseasePHARMACYCLICS LLC·Filed 2024·Application pending·0 cites
- 0885US2024293408A1Methods of treating and preventing graft versus host diseasePHARMACYCLICS LLC·Filed 2023·Application pending·0 cites
- 0979US8591892B2FTY720 increases CD74 expression and sensitizes cancer cells to anti-CD74 antibody-mediated cell deathALINARI LAPO·Filed 2012·Granted Nov 26, 2013·8 cites·48 claims
- 1079US2023097340A1Methods of treating and preventing graft versus host diseasePHARMACYCLICS LLC·Filed 2022·Application pending·0 cites
- 1177US8318812B2Therapeutic agents for the treatment of lymphoid malignanciesBYRD JOHN C·Filed 2007·Granted Nov 27, 2012·1 cites·11 claims
- 1271US2021121463A1Methods of treating and preventing graft versus host diseasePHARMACYCLICS LLC·Filed 2020·Application pending·0 cites
- 1370US8633161B2Therapeutic agents for the treatment of leukemiaPERROTTI DANILO·Filed 2006·Granted Jan 21, 2014·2 cites·5 claims
- 1462US2019388471A1Treatment of cancer using anti-cd19 chimeric antigen receptorNOVARTIS AG·Filed 2019·Application pending·0 cites
- 1562US2020147084A1Tec family kinase inhibitor adjuvant therapyPHARMACYCLICS LLC·Filed 2019·Application pending·0 cites
- 1659US2011027798A1Hybridization Quantitation Method for Modified Micro-RNA and -DNA Based OligonucleotidesUNIV OHIO STATE RES FOUND·Filed 2009·Application pending·0 cites
- 1759US2014371241A1Tec family kinase inhibitor adjuvant therapyPHARMACYCLICS INC·Filed 2014·Application pending·0 cites
- 1855US2018071293A1Tec family kinase inhibitor adjuvant therapyPHARMACYCLICS LLC·Filed 2017·Application pending·0 cites
- 1951US2011280913A1Methods and Compositions for Delivering Therapeutic Agents in the Treatment of B-Cell Related DisordersBYRD JOHN C·Filed 2009·Application pending·0 cites
- 2048US2014056917A1FTY720 Increases CD74 Expression and Sensitizes Cancer Cells to Anti-CD74 Antibody-Mediated Cell DeathIMMUNOMEDICS INC·Filed 2013·Application pending·0 cites
- 2133US2018140602A1Combination of chimeric antigen receptor therapy and amino pyrimidine derivativesANGST DANIELA·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Natarajan Muthusamy files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →